Narayanan, S.; Fan, Y.-F.; Gujarati, N.A.; Teng, Q.-X.; Wang, J.-Q.; Cai, C.-Y.; Yang, Y.; Chintalapati, A.J.; Lei, Y.; Korlipara, V.L.;
et al. VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study. Cancers 2021, 13, 4675.
https://doi.org/10.3390/cancers13184675
AMA Style
Narayanan S, Fan Y-F, Gujarati NA, Teng Q-X, Wang J-Q, Cai C-Y, Yang Y, Chintalapati AJ, Lei Y, Korlipara VL,
et al. VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study. Cancers. 2021; 13(18):4675.
https://doi.org/10.3390/cancers13184675
Chicago/Turabian Style
Narayanan, Silpa, Ying-Fang Fan, Nehaben A. Gujarati, Qiu-Xu Teng, Jing-Quan Wang, Chao-Yun Cai, Yuqi Yang, Anirudh J. Chintalapati, Yixiong Lei, Vijaya L. Korlipara,
and et al. 2021. "VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study" Cancers 13, no. 18: 4675.
https://doi.org/10.3390/cancers13184675
APA Style
Narayanan, S., Fan, Y. -F., Gujarati, N. A., Teng, Q. -X., Wang, J. -Q., Cai, C. -Y., Yang, Y., Chintalapati, A. J., Lei, Y., Korlipara, V. L., & Chen, Z. -S.
(2021). VKNG-1 Antagonizes ABCG2-Mediated Multidrug Resistance via p-AKT and Bcl-2 Pathway in Colon Cancer: In Vitro and In Vivo Study. Cancers, 13(18), 4675.
https://doi.org/10.3390/cancers13184675
